Publication|Articles|February 18, 2026
- Pharmaceutical Executive: February 2026
- Volume 46
- Issue 1
Pharmaceutical Executive: February 2026 Interactive Digital Edition
View the Pharmaceutical Executive February 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
27 days ago
A New Pharma Playbookabout 1 month ago
Taking Advantage of ‘Hidden Gem’ Talent Hubsabout 1 month ago
Your Phase III Clinical Protocol Is Your Initial Product Launchabout 2 months ago
To Build or to Buy: Determining Your AI PathNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
3
Cautious Momentum: Biopharma Review and Outlook
4
Moving CAR-T Beyond Oncology
5
